Related Experiment Videos
Conversion to estriol in "normal", benign and malignant human breast tissues
R Seshadri1, N D Bagli-Vania, J N Suraiya
1Endocrinology Unit, Tata Memorial Hospital, Parel, Bombay, India.
Journal of Cancer Research and Clinical Oncology
|January 1, 1990
Summary
16 alpha-hydroxylase activity was detected in 58% of malignant human breast tumors but not in normal or benign tissues. This enzyme may serve as a metabolic marker for breast cancer detection.
Area of Science:
- Biochemistry
- Oncology
- Endocrinology
Background:
- Controversial reports exist regarding 16 alpha-hydroxylase activity in human breast tumors.
- Understanding enzyme activity in breast tissue is crucial for cancer research.
Purpose of the Study:
- To investigate 16 alpha-hydroxylase enzyme activity in normal, benign, and malignant human breast tissues.
- To determine if 16 alpha-hydroxylase activity can serve as a metabolic marker for breast cancer.
Main Methods:
- Enzyme activity was measured by assessing the conversion of estradiol to estriol.
- Breast tissues were categorized as normal, benign, or malignant.
Main Results:
- 16 alpha-hydroxylase activity was detected in 8 out of 14 (58%) malignant breast tumors.
- No detectable 16 alpha-hydroxylase activity was found in normal or benign breast tissues.
Conclusions:
- The findings suggest that 16 alpha-hydroxylase activity is specific to malignant breast tumors.
- Further extensive studies are warranted to validate its potential as an additional metabolic marker for human breast cancer.